These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9598857)

  • 1. Acute tumor lysis syndrome after transcatheter chemoembolization of hepatocellular carcinoma.
    Burney IA
    South Med J; 1998 May; 91(5):467-70. PubMed ID: 9598857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: case reports and literature review.
    Hsieh PM; Hung KC; Chen YS
    World J Gastroenterol; 2009 Oct; 15(37):4726-8. PubMed ID: 19787837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute tumor lysis syndrome caused by transcatheter oily chemoembolization in a patient with a large hepatocellular carcinoma.
    Sakamoto N; Monzawa S; Nagano H; Nishizaki H; Arai Y; Sugimura K
    Cardiovasc Intervent Radiol; 2007; 30(3):508-11. PubMed ID: 17242878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient.
    Kim JO; Jun DW; Tae HJ; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC; Hahm JS
    Clin Mol Hepatol; 2015 Mar; 21(1):85-8. PubMed ID: 25834806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
    Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
    J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity reactions to transcatheter chemoembolization with cisplatin and Lipiodol suspension for unresectable hepatocellular carcinoma.
    Kawaoka T; Aikata H; Katamura Y; Takaki S; Waki K; Hiramatsu A; Takahashi S; Hieda M; Kakizawa H; Chayama K
    J Vasc Interv Radiol; 2010 Aug; 21(8):1219-25. PubMed ID: 20619676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma.
    Tsai WL; Liang PC; Chen CH
    J Formos Med Assoc; 2012 Dec; 111(12):724-5. PubMed ID: 23265753
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma.
    Shiba H; Ishida Y; Wakiyama S; Sakamoto T; Misawa T; Yanaga K
    Cancer Sci; 2008 Oct; 99(10):2104-5. PubMed ID: 19016772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
    Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute tumor lysis syndrome after transarterial chemoembolization for well-differentiated hepatocellular carcinoma with neuroendocrine features.
    Wang K; Chen Z
    Onkologie; 2010; 33(10):532-5. PubMed ID: 20926901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter arterial chemoembolization with fine-powder cisplatin-lipiodol for HCC.
    Koizumi Y; Hirooka M; Uehara T; Kisaka Y; Uesugi K; Kumagi T; Abe M; Matsuura B; Hiasa Y; Onji M
    Hepatogastroenterology; 2011; 58(106):512-5. PubMed ID: 21661422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of arterial phase CT for prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: a retrospective analysis.
    Katyal S; Oliver JH; Peterson MS; Chang PJ; Baron RL; Carr BI
    AJR Am J Roentgenol; 2000 Dec; 175(6):1665-72. PubMed ID: 11090401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Lysis Syndrome: A Serious Complication of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
    Jiang RD; Jian WC; Jin N; Zhang ZL; Li T
    Am J Med; 2016 Sep; 129(9):e173-6. PubMed ID: 27155110
    [No Abstract]   [Full Text] [Related]  

  • 14. Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization.
    Iwasa S; Ikeda M; Okusaka T; Ueno H; Morizane C; Nakachi K; Mitsunaga S; Kondo S; Hagihara A; Shimizu S; Satake M; Arai Y
    Jpn J Clin Oncol; 2011 Jun; 41(6):770-5. PubMed ID: 21459893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of unresectable hepatoma to resectable. Report of a case and review of the literature.
    Tepetes KN; Tsamandas AC; Felekouras ES; Salakou SG; Karavias DD
    Hepatogastroenterology; 2000; 47(34):1105-9. PubMed ID: 11020889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter arterial chemotherapy using miriplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Imai N; Ikeda K; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Jpn J Clin Oncol; 2012 Mar; 42(3):175-82. PubMed ID: 22210921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
    Takaki Y; Kaminou T; Shabana M; Ihaya T; Otsubo K; Ogawa T
    Hepatogastroenterology; 2008; 55(81):202-6. PubMed ID: 18507107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
    Seki A; Hori S
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.